allicin has been researched along with Multiple Myeloma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Y; He, W; Liu, B; Wang, X; Zeng, J; Zheng, Y | 1 |
1 other study(ies) available for allicin and Multiple Myeloma
| Article | Year |
|---|---|
Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway.
Topics: Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Databases, Genetic; Dexamethasone; Disulfides; Drug Resistance, Neoplasm; Drug Synergism; G1 Phase Cell Cycle Checkpoints; Humans; MicroRNAs; Multiple Myeloma; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; S Phase Cell Cycle Checkpoints; Sex-Determining Region Y Protein; Side-Population Cells; Signal Transduction; Spheroids, Cellular; Sulfinic Acids; TOR Serine-Threonine Kinases | 2021 |